As shown in Table 4, therapeutic strategies for counteracting ALDH2 deficiency in DCM include ALDH2 activators, SGLT2 inhibitors, antioxidants, and anti-inflammatory agents. The gene discussed is ALDH2; the disease is familial dilated cardiomyopathy.